208 related articles for article (PubMed ID: 32879207)
21. Comparison of cisplatin-induced nephrotoxicity between single-dose and split-dose administration to rats.
Fukushima K; Futatsugi A; Maekawa M; Naito S; Okada A; Sugioka N
Biomed Pharmacother; 2022 Mar; 147():112619. PubMed ID: 34999374
[TBL] [Abstract][Full Text] [Related]
22. Renoprotective effects of angiotensin receptor blocker and stem cells in acute kidney injury: Involvement of inflammatory and apoptotic markers.
Sherif IO; Al-Mutabagani LA; Alnakhli AM; Sobh MA; Mohammed HE
Exp Biol Med (Maywood); 2015 Dec; 240(12):1572-9. PubMed ID: 25825359
[TBL] [Abstract][Full Text] [Related]
23. Effect of ginsenoside Rh
Qi Z; Li W; Tan J; Wang C; Lin H; Zhou B; Liu J; Li P
Phytomedicine; 2019 Aug; 61():152862. PubMed ID: 31048124
[TBL] [Abstract][Full Text] [Related]
24. Effects of disopyramide and verapamil on renal disposition and nephrotoxicity of cisplatin in rats.
Hanada K; Odaka K; Kudo A; Ogata H
Pharm Res; 1999 Oct; 16(10):1589-95. PubMed ID: 10554102
[TBL] [Abstract][Full Text] [Related]
25. Potentiation of cisplatin-induced nephrotoxicity in rats by allopurinol.
Erdinç M; Erdinç L; Nergiz Y; Işik B
Exp Toxicol Pathol; 2000 Aug; 52(4):329-34. PubMed ID: 10987186
[TBL] [Abstract][Full Text] [Related]
26. Evaluation of the effect of glutathione on cisplatin antitumor activity and kidney injury at different administration times.
Xu YY; Jiang N; Liu TS; Qu HQ; Wang T
Mol Med Rep; 2012 Nov; 6(5):1075-80. PubMed ID: 22895541
[TBL] [Abstract][Full Text] [Related]
27. Administration of vitamin E and losartan as prophylaxes in cisplatin-induced nephrotoxicity model in rats.
Nematbakhsh M; Ashrafi F; Safari T; Talebi A; Nasri H; Mortazavi M; Khazaei M; Baradaran-Mahdavi MM
J Nephrol; 2012; 25(3):410-7. PubMed ID: 21928232
[TBL] [Abstract][Full Text] [Related]
28. Enhancement of Cisplatin Nephrotoxicity by Morphine and Its Attenuation by the Opioid Antagonist Naltrexone.
Aminian A; Javadi S; Rahimian R; Dehpour AR; Asadi Amoli F; Moghaddas P; Ejtemaei Mehr S
Acta Med Iran; 2016 Jul; 54(7):422-9. PubMed ID: 27424012
[TBL] [Abstract][Full Text] [Related]
29. Time-dependent nephrotoxicity associated with daily administration of cisplatin in mice.
To H; Kikuchi A; Tsuruoka S; Sugimoto K; Fujimura A; Higuchi S; Kayama F; Hara K; Matsuno K; Kobayashi E
J Pharm Pharmacol; 2000 Dec; 52(12):1499-504. PubMed ID: 11197078
[TBL] [Abstract][Full Text] [Related]
30. Kidney Protection Effect of Ginsenoside Re and Its Underlying Mechanisms on Cisplatin-Induced Kidney Injury.
Wang Z; Li YF; Han XY; Sun YS; Zhang LX; Liu W; Liu XX; Li W; Liu YY
Cell Physiol Biochem; 2018; 48(5):2219-2229. PubMed ID: 30110677
[TBL] [Abstract][Full Text] [Related]
31. Population Pharmacokinetic-Toxicodynamic Modeling and Simulation of Cisplatin-Induced Acute Renal Injury in Rats: Effect of Dosing Rate on Nephrotoxicity.
Fukushima K; Okada A; Sasaki K; Kishimoto S; Fukushima S; Hamori M; Nishimura A; Shibata N; Shirai T; Terauchi R; Kubo T; Sugioka N
J Pharm Sci; 2016 Jan; 105(1):324-32. PubMed ID: 26852862
[TBL] [Abstract][Full Text] [Related]
32. Antitumor effectiveness and toxicity of cisplatin-loaded long-circulating and pH-sensitive liposomes against Ehrlich ascitic tumor.
de Carvalho Maroni L; de Oliveira Silveira AC; Leite EA; Melo MM; de Carvalho Ribeiro AF; Cassali GD; de Souza CM; Souza-Fagundes EM; Caldas IR; Araújo MS; Martins-Filho OA; de Oliveira MC; Teixeira-Carvalho A
Exp Biol Med (Maywood); 2012 Aug; 237(8):973-84. PubMed ID: 22903135
[TBL] [Abstract][Full Text] [Related]
33. Studies on nephrotoxicity following a single and repeated administration of cis-diamminedichloroplatinum (CDDP) in rats.
Mizushima Y; Nagahama H; Yokoyama A; Morikage T; Yano S
Tohoku J Exp Med; 1987 Feb; 151(2):129-35. PubMed ID: 3576612
[TBL] [Abstract][Full Text] [Related]
34. [Experimental studies of the protective effect of deferoxamine mesilate on cisplatin induced toxicity].
Watanabe H; Kanno H
Nihon Jibiinkoka Gakkai Kaiho; 1998 Aug; 101(8):967-78. PubMed ID: 9778942
[TBL] [Abstract][Full Text] [Related]
35. Protective effects of dendropanoxide isolated from Dendropanax morbifera against cisplatin-induced acute kidney injury via the AMPK/mTOR signaling pathway.
Park YJ; Kim KS; Park JH; Lee SH; Kim HR; Lee SH; Choi HB; Cao S; Kumar V; Kwak JH; Kim HS
Food Chem Toxicol; 2020 Nov; 145():111605. PubMed ID: 32750447
[TBL] [Abstract][Full Text] [Related]
36. β-Hydroxybutyrate Protects Against Cisplatin-Induced Renal Damage via Regulating Ferroptosis.
Tian R; Tang S; Zhao J; Hao Y; Zhao L; Han X; Wang X; Zhang L; Li R; Zhou X
Ren Fail; 2024 Dec; 46(1):2354918. PubMed ID: 38757723
[TBL] [Abstract][Full Text] [Related]
37. Celecoxib, a selective cyclooxygenase-2 inhibitor, attenuates renal injury in a rat model of Cisplatin-induced nephrotoxicity.
Suddek GM; El-Kenawi AE; Abdel-Aziz A; El-Kashef HA
Chemotherapy; 2011; 57(4):321-6. PubMed ID: 21893983
[TBL] [Abstract][Full Text] [Related]
38. [Effects of urinastatin against nephrotoxicity of cisplatinum].
Arakawa A; Kato N; Asai H; Yasui Y; Suzumori K; Suzumori K; Yagami Y
Gan To Kagaku Ryoho; 1990 Nov; 17(11):2229-34. PubMed ID: 2241187
[TBL] [Abstract][Full Text] [Related]
39. Synergistic protective effect of
Abdel-Wahab WM; Moussa FI; Saad NA
Drug Des Devel Ther; 2017; 11():901-908. PubMed ID: 28356716
[TBL] [Abstract][Full Text] [Related]
40. Effects of mycophenolate mofetil on cisplatin-induced renal dysfunction in rats.
Saad SY; Arafah MM; Najjar TA
Cancer Chemother Pharmacol; 2007 Mar; 59(4):455-60. PubMed ID: 16855841
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
